(EMAILWIRE.COM, July 30, 2019 ) The market growth is primarily driven by the rising incidence of infectious diseases coupled with epidemic and pandemic outbreaks, increasing food safety concerns, technological advancements in microbial identification techniques, and government initiatives and funding to promote microbial identification.

The microbial identification market is expected to reach USD 3.00 Billion by 2022 from USD 2.04 Billion in 2016 at a CAGR of 6.6%.

Market Dynamics

+ Drivers
+ Rising Incidence of Infectious Diseases Coupled with Epidemic and Pandemic Events
+ Technological Advancements in Microbial Identification
+ Increasing Food Safety Concerns
+ Government Initiatives and Funding for Promoting Microbial Identification

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10702182

The market is segmented into phenotypic, genotypic, and proteomics-based methods. The phenotypic methods segment is anticipated to account for the largest share of the global microbial identification market in 2017. These methods are cost-effective, easy to perform, and can deliver results rapidly. Therefore, they are widely adopted across industries, which is a major factor responsible for the large share of this segment.

The microbial identification market is categorized into hospitals, diagnostic laboratories, and blood banks; food manufacturing companies; beverage manufacturing companies; pharmaceutical companies and CROs; and other end users. The hospitals, diagnostic laboratories, and blood banks segment is estimated to account for the largest share of the global microbial identification market in 2017. The heavy burden of different infectious diseases, along with periodic outbreaks of pandemic and epidemic diseases are the key factors driving the growth of this end user segment.

View complete press release:-
https://www.marketsandmarkets.com/PressReleases/microbial-identification.asp